|

Donor Hematopoietic Stem and Progenitor Cell Infusion Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Donor HSPC Infusion

Pipeline

Phase 1/2: 1

Top Sponsors

  • University of California, Los Angeles1

Indications

  • Immunosuppression Disorders1
  • Immunosuppression After Liver Transplantation1
  • Chimerism1
  • Hematopoietic Stem Cell1
  • Graft Survival1

Los Angeles, California1 trial

Immune Tolerance Induction After Liver Transplantation

UCLA Health 200 Medical Plaza

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.